| Financial Year |
March 31 2023 |
| Monetary Funds |
1,951,194,564.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
28,923,422.02 |
| Accounts Receivable |
3,013,328,180.70 |
| Advances to Suppliers |
134,587,398.05 |
| Other Receivables |
85,603,800.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,903,570,616.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,506,227.51 |
| Other Current Assets |
145,417,629.60 |
| Total Current Assets |
10,181,822,729.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
81,305,647.09 |
| Long-term Equity Investment |
168,917,225.99 |
| Investment Properties |
98,440,085.40 |
| Fixed Assetes |
1,628,857,260.93 |
| Under-construction Projects |
21,020,962.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
449,276,071.38 |
| R&D expenses |
-- |
| Goodwill |
762,552,314.83 |
| Long-Term Deferred and Prepaid Expenses |
84,406,646.64 |
| Deferred Income Tax Assets |
283,808,458.75 |
| Other Non-Current Assets |
239,018,332.03 |
| Sub-Total of Non-Current Assets |
4,120,323,286.96 |
| Total Assets |
14,302,146,015.99 |
| Short-Term Loans |
579,848,426.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
631,167,571.59 |
| Accounts Payable |
1,838,096,016.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
90,056,050.22 |
| Taxes Payable |
230,537,220.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,797,513.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
294,905,014.35 |
| Other Current Liabilities |
257,775,798.09 |
| Sub-Total of Current Liabilities |
4,766,293,660.63 |
| Long-term Loans |
84,042,253.22 |
| Bonds Payable |
706,166,707.44 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
100,736,595.63 |
| Deferred Income Tax Liabilities |
83,666,840.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,171,527,010.93 |
| Total Liabilities |
5,937,820,671.56 |
| Paid-In Capital(Or Share Stock) |
2,529,396,015.00 |
| Capital Surplus |
1,941,809,661.58 |
| Surplus Reserve |
156,386,637.49 |
| LESS:Treasury Stock |
9,432,745.11 |
| Undistributed Profits |
3,460,612,092.28 |
| Minority Stockholder's Interest |
216,527,855.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,147,797,488.60 |
| Owner's Equity（Stockholder's Equity） |
8,364,325,344.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,302,146,015.99 |
